Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor necrosis factor-inducible gene 6 reprograms hepatic stellate cells into stem-like cells, which ameliorates liver damage in mouse
Sihyung Wang, Ji‐Eun Kim, Chanbin Lee, et al.
Biomaterials (2019) Vol. 219, pp. 119375-119375
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Mesenchymal stem cell therapy for liver disease: full of chances and challenges
Xue Yang, Yan Meng, Zhipeng Han, et al.
Cell & Bioscience (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 87
Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis
Chanbin Lee, Ji‐Eun Kim, Jinsol Han, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 54
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics
Xiao Ma, Tengda Huang, Xi Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p
Jieun Kim, Chanbin Lee, Yongbo Shin, et al.
Molecular Therapy (2020) Vol. 29, Iss. 4, pp. 1471-1486
Open Access | Times Cited: 52
Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis
Anshika Jangra, Ashish Kothari, Phulen Sarma, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1500-1500
Open Access | Times Cited: 33
Mesenchymal Stromal/Stem Cells and Their Extracellular Vesicles Application in Acute and Chronic Inflammatory Liver Diseases: Emphasizing on the Anti-Fibrotic and Immunomodulatory Mechanisms
Ali Hazrati, Kosar Malekpour, Sara Soudi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Abnormal metabolism in hepatic stellate cells: Pandora's box of MAFLD related hepatocellular carcinoma
Yuan-dong Sun, Hao Zhang, Yuanmin Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189086-189086
Closed Access | Times Cited: 7
Organoid of ovarian cancer: genomic analysis and drug screening
Huidong Liu, Bairong Xia, Mingzhu Jin, et al.
Clinical & Translational Oncology (2020) Vol. 22, Iss. 8, pp. 1240-1251
Open Access | Times Cited: 48
Structural and Temporal Dynamics of Mesenchymal Stem Cells in Liver Diseases From 2001 to 2021: A Bibliometric Analysis
Bo Shao, Yafei Qin, Shaohua Ren, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Epigenetic silencing of LncRNA ANRIL enhances liver fibrosis and HSC activation through activating AMPK pathway
Jing‐Jing Yang, Yang Yang, Chong Zhang, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 4, pp. 2677-2687
Open Access | Times Cited: 39
Applications of Mesenchymal Stem Cells in Liver Fibrosis: Novel Strategies, Mechanisms, and Clinical Practice
Mengmei Zhu, Tianzhen Hua, Tao Ouyang, et al.
Stem Cells International (2021) Vol. 2021, pp. 1-17
Open Access | Times Cited: 29
Mesenchymal Stem Cells Influence Activation of Hepatic Stellate Cells, and Constitute a Promising Therapy for Liver Fibrosis
Chanbin Lee, Min-Ju Kim, Jinsol Han, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1598-1598
Open Access | Times Cited: 28
Transplantation of adipose-derived stem cells ameliorates Echinococcus multilocularis-induced liver fibrosis in mice
Ning Yang, Wenmei Ma, Ying Ke, et al.
PLoS neglected tropical diseases (2022) Vol. 16, Iss. 1, pp. e0010175-e0010175
Open Access | Times Cited: 18
Recent advances of nanomaterials in imaging liver fibrosis
Jin Cui, Shuxuan Zhang, Xueli Xu, et al.
BMEMat (2024)
Open Access | Times Cited: 3
Efficient and targeted chemo-gene delivery with self-assembled fluoro-nanoparticles for liver fibrosis therapy and recurrence
Pengkai Wu, Xinping Luo, Hui Wu, et al.
Biomaterials (2020) Vol. 261, pp. 120311-120311
Closed Access | Times Cited: 27
Bone mesenchymal stem cells improve cholestatic liver fibrosis by targeting ULK1 to regulate autophagy through PI3K/AKT/mTOR pathway
Tingjuan Huang, Chunhong Zhang, Ziyi Shang, et al.
Stem Cells Translational Medicine (2024) Vol. 13, Iss. 7, pp. 648-660
Open Access | Times Cited: 3
TSG-6 Inhibits the NF-κB Signaling Pathway and Promotes the Odontogenic Differentiation of Dental Pulp Stem Cells via CD44 in an Inflammatory Environment
Ying Wang, Yulang Xie, Ningning Xue, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 368-368
Open Access | Times Cited: 2
Tumor necrosis factor-inducible gene 6 protein and its derived peptide ameliorate liver fibrosis by repressing CD44 activation in mice with alcohol-related liver disease
Jinsol Han, Chanbin Lee, Hayeong Jeong, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 2
Current Therapeutic Options and Potential of Mesenchymal Stem Cell Therapy for Alcoholic Liver Disease
Jinsol Han, Chanbin Lee, Jin Hur, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 22-22
Open Access | Times Cited: 11
Targeted activation ofHNF4α/HGF1/FOXA2reverses hepatic fibrosis via exosome-mediated delivery of CRISPR/dCas9-SAM system
Nianan Luo, Wenjun Zhong, Jiangbin Li, et al.
Nanomedicine (2022) Vol. 17, Iss. 20, pp. 1411-1427
Closed Access | Times Cited: 10
KRT17 Promotes the Activation of HSCs via EMT in Liver Fibrosis
Jing Chen, Sijia Ge, Hai-Juan Feng, et al.
Journal of Clinical and Translational Hepatology (2021) Vol. 10, Iss. 2, pp. 207-218
Open Access | Times Cited: 11
TSG-6 inhibits the NF-κB signaling pathway and promotes the odontogenic differentiation of DPSCs via CD44 in an inflammatory environment
Ying Wang, Yulang Xie, Ningning Xue, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
An update on the role of tumor necrosis factor alpha stimulating gene-6 in inflammatory diseases
Ruomei Li, Chengjie Ji, Mengmeng Dai, et al.
Molecular Immunology (2022) Vol. 152, pp. 224-231
Open Access | Times Cited: 7
Tumor necrosis factor-inducible gene 6 interacts with CD44, which is involved in fate-change of hepatic stellate cells
Sihyung Wang, Jieun Kim, Chanbin Lee, et al.
BMB Reports (2020) Vol. 53, Iss. 8, pp. 425-430
Open Access | Times Cited: 8
Nanotechnology-based combinational strategies toward the regulation of myofibroblasts and diseased microenvironment in liver fibrosis and hepatic carcinoma
Fenfen Li, Ying Zhao, Guangjun Nie
Nano Research (2023) Vol. 16, Iss. 12, pp. 13042-13055
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top